Literature DB >> 21983933

Analysis of stromal cells in osteofibrous dysplasia and adamantinoma of long bones.

Richard M Taylor1, Takeshi G Kashima, David J Ferguson, Károly Szuhai, Pancras C Hogendoorn, Nicholas A Athanasou.   

Abstract

Adamantinoma of long bones and osteofibrous dysplasia are rare, osteolytic primary bone tumours of uncertain origin containing areas of fibrous and fibro-osseous proliferation. We investigated the nature of the stromal cells in adamantinoma of long bones and osteofibrous dysplasia, and determined cellular and molecular mechanisms of osteolysis in these tumours. Cell culture, molecular (RT-PCR, western blot) and immunohistochemical studies on cases of adamantinoma of long bones and of osteofibrous dysplasia were undertaken to determine the expression of epithelial, osteoblast and osteoclast markers. Ultrastructural and immunophenotypic studies on cultured adamantinoma and osteofibrous dysplasia stromal cells showed that these cells were mainly fibroblast-like with few cells expressing epithelial markers. Osteofibrous dysplasia but not adamantinoma cells expressed alkaline phosphatase. Both osteofibrous dysplasia and adamantinoma cells expressed the ostoclastogenic factors M-CSF and RANKL. Adamantinoma and osteofibrous dysplasia cells also expressed messenger RNA for osteocalcin, osteonectin, osteopontin, osterix and collagen type 1. Adamantinoma and osteofibrous dysplasia cells cultured alone on dentine slices were not capable of lacunar resorption, but in co-cultures with monocytes induced formation of osteoclast-like cells was observered. Cultured osteofibrous dysplasia and adamantinoma stromal cells show similar ultrastructural and immunophenotypic characteristics, and differentially express osteoblast markers. Promotion of osteoclastogenesis by stromal cells may contribute to osteolysis in adamantinoma of long bones and osteofibrous dysplasia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21983933     DOI: 10.1038/modpathol.2011.141

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  5 in total

1.  Mutations Preventing Regulated Exon Skipping in MET Cause Osteofibrous Dysplasia.

Authors:  Mary J Gray; Peter Kannu; Swarkar Sharma; Christine Neyt; Dongping Zhang; Nandina Paria; Philip B Daniel; Heather Whetstone; Hans-Georg Sprenger; Philipp Hammerschmidt; Angela Weng; Lucie Dupuis; Rebekah Jobling; Roberto Mendoza-Londono; Michael Dray; Peiqiang Su; Megan J Wilson; Raj P Kapur; Edward F McCarthy; Benjamin A Alman; Andrew Howard; Gino R Somers; Christian R Marshall; Simon Manners; Adrienne M Flanagan; Karl E Rathjen; Lori A Karol; Haemish Crawford; David M Markie; Jonathan J Rios; Carol A Wise; Stephen P Robertson
Journal:  Am J Hum Genet       Date:  2015-12-03       Impact factor: 11.025

2.  Adamantinomatous tumors: Long-term follow-up study of 20 patients treated at a single institution.

Authors:  Eugenia Schwarzkopf; Yoely Tavarez; John H Healey; Meera Hameed; Daniel E Prince
Journal:  J Surg Oncol       Date:  2020-04-25       Impact factor: 3.454

Review 3.  Adamantinoma: An Updated Review.

Authors:  Dimitrios N Varvarousis; Georgios P Skandalakis; Alexandra Barbouti; Georgios Papathanakos; Panagiotis Filis; Kostas Tepelenis; Aikaterini Kitsouli; Panagiotis Kanavaros; Panagiotis Kitsoulis
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

4.  Focal fibrocartilaginous dysplasia in the thoracic vertebra: A case report.

Authors:  Bo Sun; Zhi Hong Zhang; Xuan Ying Chen; Shan Hu Huang; Zhi Li Liu
Journal:  Oncol Lett       Date:  2014-07-09       Impact factor: 2.967

5.  MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of bone.

Authors:  Ting Wang; Huabin Yin; Jing Wang; Zhenxi Li; Haifeng Wei; Zhi'an Liu; Zhipeng Wu; Wangjun Yan; Tielong Liu; Dianwen Song; Xinghai Yang; Quan Huang; Wang Zhou; Jianru Xiao
Journal:  Oncotarget       Date:  2015-08-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.